8-KFiled Jul 23, 8:00 PM ET

Daré Bioscience Files Reg FD Corporate Presentation (July 24, 2026)

$DARE · Dare Bioscience, Inc.

Research Summary

AI-generated summary of this SEC filing

Updated

Daré Bioscience Files Reg FD Corporate Presentation (July 24, 2026)

What Happened

  • Daré Bioscience, Inc. (DARE) filed a Form 8-K on July 24, 2026 to disclose a corporate presentation furnished under Regulation FD.
  • The presentation (Exhibit 99.1), dated July 24, 2026, will be used in meetings with securities market participants starting July 24, 2026 and will be made available on Daré’s investor website under “Presentations, Events & Webcasts.”
  • The company noted that information on its website or other sites referenced in the presentation is not incorporated by reference into the 8-K.

Key Details

  • Filing date: July 24, 2026 (Form 8-K).
  • Exhibit provided: 99.1 — Daré corporate presentation dated July 24, 2026.
  • Availability: Presentation to be posted at https://ir.darebioscience.com (Investors → Presentations, Events & Webcasts → Presentations).
  • Regulation FD: Furnished under Reg FD to broadly disseminate the presentation content to market participants.

Why It Matters

  • This filing signals Daré is broadly sharing updated corporate information with investors and market participants; the presentation is the primary source for any near-term company updates disclosed in these meetings.
  • Retail investors should review the posted presentation on the investor website to see any operational, strategic, or timing information the company is presenting, since the 8-K itself only furnishes (rather than incorporates) that material.